Freestone Capital Holdings’s iShares iBonds Dec 2032 Term Corporate ETF IBDX Stock Holding History
Bought
Maintained
Sold
Other funds holding IBDX
ACA
CIA
CAI
SF
SIC
KA
Freestone Capital Holdings's IBDX Position: Q1 2026 in Review
Freestone Capital Holdings reduced its iShares iBonds Dec 2032 Term Corporate ETF (IBDX) stake by 29% in Q1 2026, selling an estimated $390K and leaving 37,245 shares worth $941K. The position accounts for 0.03% of the portfolio, ranked #241.
Freestone Capital Holdings first reported a position in IBDX in Q3 2025 and has held it in 3 quarters since. The position peaked at $1.34M in Q4 2025. 221 funds tracked by Wall St. Rank hold IBDX as of Q1 2026.
- Freestone Capital Holdings held 37,245 shares of iShares iBonds Dec 2032 Term Corporate ETF worth $941K as of Q1 2026.
- Freestone Capital Holdings sold 15,282 iShares iBonds Dec 2032 Term Corporate ETF shares in Q1 2026, an estimated $390K.
- iShares iBonds Dec 2032 Term Corporate ETF made up 0.03% of Freestone Capital Holdings's portfolio in Q1 2026, its #241 holding.
- Freestone Capital Holdings first reported a position in iShares iBonds Dec 2032 Term Corporate ETF in Q3 2025 and has held it in 3 quarters since.
- Freestone Capital Holdings's iShares iBonds Dec 2032 Term Corporate ETF position peaked at $1.34M in Q4 2025.
- 221 funds tracked by Wall St. Rank held iShares iBonds Dec 2032 Term Corporate ETF as of Q1 2026.
Based on Freestone Capital Holdings's 13F filing for Q1 2026, filed 13 May 2026.